What this deck covers
This deck focuses on Medication Error Reporting, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Study Medication Error Reporting in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
Which structured method is commonly used after serious harm to identify root causes and fixes?
Tap card or press Space to flip
Root cause analysis (RCA). RCA systematically identifies contributing factors and develops corrective actions, essential for addressing serious errors in healthcare settings.
How well did you know it?
Card 1 / 23
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Medication Error Reporting, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Root cause analysis (RCA). RCA systematically identifies contributing factors and develops corrective actions, essential for addressing serious errors in healthcare settings.
Answer: D: monitoring/intervention to prevent harm; E: temporary harm occurred. Distinction lies in outcome: D prevents harm through intervention, while E involves actual temporary harm, aiding accurate error classification.
Answer: Category I. This highest severity category ensures focused review of fatal errors to implement critical safeguards against recurrence.
Answer: Balance learning and accountability; avoid blame for human error. Just culture promotes reporting by focusing on system improvements and fair accountability, reducing fear of punishment for unintentional errors.
Answer: Nonpunitive, confidential, easy-to-use reporting process. These features encourage voluntary reporting of near misses, providing data for proactive safety improvements before harm occurs.
Answer: Near miss. Interception before dispensing prevents patient exposure, classifying it as a near miss for learning without actual harm.
Answer: Category A. This category identifies potential risks without actual errors, enabling proactive system improvements to avert future medication mishaps.
Answer: ISMP Medication Errors Reporting Program (MERP). MERP facilitates anonymous national reporting, enabling ISMP to analyze trends and disseminate safety alerts to prevent widespread errors.
Answer: No-harm event (NCC MERP Category C or D). These categories capture errors that reach patients without causing harm, aiding in identifying process weaknesses before serious incidents occur.
Answer: MedWatch. MedWatch supports post-marketing surveillance by collecting voluntary reports, aiding FDA in identifying and addressing medication safety issues.
Answer: Subjective opinions or accusatory statements about individuals. Excluding bias maintains objectivity, fostering a culture of learning and system improvement rather than individual blame in error analysis.
Answer: Unexpected event involving death or serious physical/psychological injury or risk. Sentinel events trigger mandatory reviews to uncover systemic failures and implement changes, enhancing overall healthcare quality and safety.
Answer: Assess the patient and ensure immediate safety. Prioritizing patient assessment addresses immediate risks, stabilizing the situation before reporting or investigating the error.
Answer: What happened, where/when, meds involved, outcome, contributing factors, actions. Including these elements ensures comprehensive documentation, facilitating accurate analysis and development of targeted prevention strategies.
Answer: Categories C and D. These categories classify errors that contact patients without harm, facilitating analysis of near-harm events for process enhancements.
Answer: Preventable event that may cause or lead to inappropriate medication use or harm. This definition emphasizes preventability and potential for harm, distinguishing errors from unavoidable adverse events in pharmacy practice.
Answer: The 5 Whys. Iterative questioning uncovers root causes beyond surface issues, enabling targeted interventions to prevent error recurrence.
Answer: VAERS. VAERS monitors vaccine safety through adverse event reports, enabling CDC and FDA to detect patterns and ensure public health protection.
Answer: Latent condition (latent failure). Latent failures represent hidden systemic weaknesses that enable active errors, requiring root cause analysis for effective prevention.
Answer: System-based error (latent failure). Latent failures stem from organizational or design flaws, necessitating systemic changes over individual training to effectively mitigate risks.
Answer: Categories E through H. These categories denote varying degrees of harm, guiding prioritization of investigations and interventions based on severity.
Answer: Near miss (close call). Detection prior to patient exposure prevents harm and provides valuable insights for improving safety protocols in medication handling.
Answer: To identify, analyze, and prevent recurrence of medication-related harm. Reporting enables systematic identification of errors, root cause analysis, and implementation of preventive measures to enhance patient safety.